The integration of the currently fragmented expertise, technologies and methodologies for 3D printing (3DP) in medical applications requires the joint effort of ‘best-in-class’ partners and collaborative work across disciplines and borders:
TUD is leading worldwide in the field of steerable medical devices; the involved research groups at UG are leading in the field of virtual optimisation and that of biomaterials for 3DP, respectively; ARMINES is well equipped with expertise on 3DP of composites; ULille has top expertise in designing drug release systems and UOx on bioresorbable materials; MTL delivers preoperative planning solutions, with the unique potential to link with postoperatory evaluation; DORC is market leader in ophthalmic surgical instruments.
The consortium also includes innovative companies (AmI, EXO-L, VIGO, 3DLP, OxMestar, Oceanz), as well as clinical observers and clusters throughout the 2Seas area, to catalyse the transfer of results to a critical mass of users.